These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10386656)

  • 1. The optimal radiotherapy schedule for T1 glottic cancers?
    Hendry JH; Slevin NJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):967-8. PubMed ID: 10386656
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical radiobiology of glottic T1 squamous cell carcinoma.
    Skladowski K; Tarnawski R; Maciejewski B; Wygoda A; Slosarek K
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):101-6. PubMed ID: 9989520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated radiotherapy for T1 to T2 glottic cancer.
    Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
    Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
    Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.
    Bledsoe TJ; Park HS; Stahl JM; Yarbrough WG; Burtness BA; Decker RH; Husain ZA
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer.
    Haugen H; Johansson KA; Mercke C
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):109-19. PubMed ID: 11777628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation.
    Dinshaw KA; Sharma V
    Indian J Cancer; 1990 Sep; 27(3):143-53. PubMed ID: 2090566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
    Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
    Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The results of radiotherapy for T1 glottic cancers; influence of radiation beam energy.
    Yamamoto M; Joja I; Takemoto M; Kuroda M; Hiraki Y
    Acta Med Okayama; 1999 Apr; 53(2):91-4. PubMed ID: 10358724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience.
    Hafidh M; Tibbo J; Trites J; Corsten G; Hart RD; Nasser J; Wilke D; Mark Taylor S
    J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):434-9. PubMed ID: 19755083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
    Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
    Stokes WA; Abbott D; Phan A; Raben D; Lanning RM; Karam SD
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1014-1021. PubMed ID: 28721883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.
    Yamazaki H; Suzuki G; Nakamura S; Yoshida K; Konishi K; Teshima T; Ogawa K
    J Radiat Res; 2017 Jul; 58(4):495-508. PubMed ID: 28898958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701).
    Nakamura K; Kodaira T; Shikama N; Kagami Y; Ishikura S; Shibata T; Hiraoka M
    Jpn J Clin Oncol; 2008 May; 38(5):387-9. PubMed ID: 18390558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.